1.What risk factors are present and are they modifiable?
Risk factors are age, gender, and ethnicity, which is unknown. None of which are modifiable. (Chisholm-Burns, Schwinghammer, Wells, Malone, Kolesar & DiPiro, 2016, p. 93).
1. What are the goals of therapy?
“To improve quality of life and to alleviate symptoms such as angina.” (Aroesty, n.d.). Patient is to be able to continue with his current lifestyle without the angina.
2. What medication(s) do you recommend to prevent Bill from experiencing angina-related chest discomfort?
ASA 81 mg, orally daily. Antianginal therapy, atenolol 25 mg orally, daily. (Chisholm-Burns, et al., p. 103).
3. What do you recommend to treat acute episodes of stable-angina-related chest discomfort?
Nitroglycerine SL: “0.3 to 0.6 mg every 5 minutes for maximum of 3 tablets in 15 minutes; may also use prophylactically 5 to 10 minutes prior to activities which may provoke an attack.” (Lexicomp, Nitroglycerine, n.d.).
4.
…show more content…
What additional medications can improve outcomes in a patient like Bill who has stable angina?
Plavix 75 mg daily, “prasugrel (Effient) and ticagrelor (Brilinta), can help prevent blood clots from forming by making your blood platelets less likely to stick together.” (Mayo Clinic, n.d.). Moderate intensity statin therapy. Simvastatin 20 mg daily. (PubMed Health, n.d.). What is your drug therapy monitoring